Research project

MINIVAN trial

Project overview

$500,000 funding from Solving Kids Cancer, $680,000 funding from BMS and $100,000 from EUSA Pharma. Juliet Gray is international lead / chief investigator

Staff

Lead researchers

Professor Juliet Gray

Professor

Research interests

  • Fc modification of monoclonal antibodies to improve effector function
Connect with Juliet

Research outputs